Imiquimod Raw Material (CAS 99011-02-6) | Genital warts drug

» Pharmaceutical » Other APIs » Imiquimod Raw Material (CAS 99011-02-6) | Genital warts drug

Imiquimod Raw Material (CAS 99011-02-6) | Genital warts drug

CATEGORY AND TAGS:
Other APIs , , , , , , ,

Molecular Formula:C14H16N4
Formula Weight: 240.3
CAS No.:99011-02-6
Appearance:white powder
Purity:99.89%

enquiry
  • Specifications

Buy Genital warts drug Imiquimod Raw Material (CAS 99011-02-6)

 

Imiquimod Description

Imiquimod is belonging to the drug for the treatment of genital warts. Clinically it can be used as the immunomodulators in the treatment of adult genital and perianal warts with convenient application, well tolerance and unique mechanism of action which makes it be the first-choice drug for treatment of genital warts.

 

Imiquimod Certificate of Analysis

Items of analysis Specification Results
Appearance Off-white powder,dissolve in hydrochloric conform
Melting point

 

297-299℃ 298.2-298.7℃
Identification IR UV/HPLC conform
Assay 98-101% 99.89%
Purity ≥99% 99.87%
Related substance ≤0.1% 0.13%
Heavy Metals ≤10ppm conform
Loss on Drying ≤0.5% ≤0.5%
Residue on ignition ≤0.2% 0.02%
Conclusion Qualified

 

Imiquimod Usage

Imiquimod can be used for the treatment of adult external genital and perianal genital warts at 3 times per week. Just before sleep, first apply the product evenly in a thin layer on the surface of the wart and gently massage until the product is completely absorbed.

The position of the medication should not be packeted and should be maintained for 6 to 10 hours, and then wash with a neutral soap and clean water for clearing the drugs in the administration site. Wash your hands before and after treatment.

250 mg of cream can be applied to 20cm2 of wart. Avoid excessive application of the drug. Patients should continue the treatment until the wart is completely cleared. Wart can be cleared within 2-4 week at the fastest speed and can be generally cleared within 8 to 12 weeks. The medication should be not more than 16 weeks.

After the treatment, patients with mild erythema locally who does not have to be discontinued for drug; if the patients feel general malaise or get local skin reactions (edema, erosion, pain, etc.), the drug should be discontinued. Only when the reaction is alleviated can they continue the medication.

Enquiry Form ( we will get back you as soon as possible )

Name:
*
Email:
*
Message:

Verification:
0 + 5 = ?

Maybe you like also

  • Product Categories

  • Recent Posts

  • Share

  • Contact Us

    E-mail: ying@wumeitech.com
    Tel: 86-0756-8811069
    Fax: 86-0756-8811095
    Tel/whatsapp: +86 17707567122
    Wicker ID: molly160529
    Telegram: +86 17707567122